Renaissance Technologies LLC raised its stake in shares of Natera, Inc. (NASDAQ:NTRA) by 28.2% during the first quarter, Holdings Channel reports. The institutional investor owned 411,400 shares of the medical research company’s stock after buying an additional 90,600 shares during the period. Renaissance Technologies LLC’s holdings in Natera were worth $3,649,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in NTRA. Massachusetts Financial Services Co. MA raised its position in Natera by 1.2% in the first quarter. Massachusetts Financial Services Co. MA now owns 16,118 shares of the medical research company’s stock valued at $143,000 after buying an additional 194 shares in the last quarter. Principal Financial Group Inc. raised its position in Natera by 0.6% in the first quarter. Principal Financial Group Inc. now owns 111,278 shares of the medical research company’s stock valued at $987,000 after buying an additional 688 shares in the last quarter. American International Group Inc. raised its position in Natera by 7.1% in the first quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock valued at $142,000 after buying an additional 1,068 shares in the last quarter. Alliancebernstein L.P. raised its position in Natera by 5.6% in the first quarter. Alliancebernstein L.P. now owns 26,600 shares of the medical research company’s stock valued at $236,000 after buying an additional 1,400 shares in the last quarter. Finally, Teachers Advisors LLC raised its position in Natera by 5.0% in the fourth quarter. Teachers Advisors LLC now owns 44,224 shares of the medical research company’s stock valued at $518,000 after buying an additional 2,116 shares in the last quarter. 59.74% of the stock is currently owned by institutional investors.

Shares of Natera, Inc. (NTRA) traded down 3.29% during midday trading on Thursday, reaching $10.01. 54,032 shares of the company’s stock were exchanged. The stock’s market cap is $531.41 million. The stock’s 50 day moving average is $10.00 and its 200-day moving average is $9.53. Natera, Inc. has a 12-month low of $7.35 and a 12-month high of $12.95.

Natera (NASDAQ:NTRA) last released its quarterly earnings results on Tuesday, August 8th. The medical research company reported ($0.52) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.52). The company had revenue of $53.60 million for the quarter, compared to the consensus estimate of $50.57 million. Natera had a negative net margin of 62.64% and a negative return on equity of 119.47%. Natera’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.46) earnings per share. On average, equities analysts expect that Natera, Inc. will post ($2.07) EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Renaissance Technologies LLC Acquires 90,600 Shares of Natera, Inc. (NTRA)” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/renaissance-technologies-llc-acquires-90600-shares-of-natera-inc-ntra/1470610.html.

Several equities analysts recently commented on the stock. ValuEngine raised shares of Natera from a “strong sell” rating to a “sell” rating in a report on Thursday. Zacks Investment Research raised shares of Natera from a “sell” rating to a “buy” rating and set a $9.25 target price on the stock in a report on Thursday. Canaccord Genuity increased their target price on shares of Natera from $14.00 to $16.00 and gave the company a “buy” rating in a report on Wednesday, May 10th. BidaskClub lowered shares of Natera from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. Finally, Morgan Stanley reduced their target price on shares of Natera from $18.00 to $13.00 and set an “overweight” rating on the stock in a report on Monday. Three equities research analysts have rated the stock with a sell rating and five have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $14.45.

Natera Company Profile

Want to see what other hedge funds are holding NTRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natera, Inc. (NASDAQ:NTRA).

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.